See how you score.
IPA Logo

More evidence, less poverty

A patient receives a dose of the COVID-19 vaccine in Nigeria

A patient receives a dose of the COVID-19 vaccine in Nigeria. Credit: i_am_zews / Shutterstock

John,

Global vaccine distribution remains highly unequal, with much of the current supply concentrated in high-income countries. Although there is sufficient supply in some countries like the U.S., vaccination rates have stagnated due to the low acceptance of the population. To better understand vaccine acceptance (willingness to get a COVID-19 vaccine) and hesitancy around the world, researchers from IPA and other research institutions surveyed nearly 45,000 people in late 2020 in 10 low- and middle-income countries (LMICs) as well as the U.S. and Russia.

What do you think they found?

  1. Vaccine acceptance was higher in the U.S. and Russia than in low- and middle-income countries.
  2. Vaccine acceptance was higher in low- and middle-income countries than in the U.S. and Russia.
  3. Vaccine acceptance was low worldwide.
  4. Vaccine acceptance was higher worldwide than previously reported.​​

Without evidence, decision-makers often have to guess the answers to questions like these. IPA works with researchers and our partners to generate evidence on what works, so organizations and governments can make informed decisions.

Support IPA - Donate Now

Thank you for taking our quiz!

Sincerely,

The IPA Team

GuideStar Platinum 2021 Seal of Transparency   BBB Accredited Charity   Recommended by The Life You Can Save
 

DONATE | RESEARCH | IMPACT | WORK WITH IPA

poverty-action.org

Find us on Facebook   Find us on Twitter   Find us on YouTube   Find us on LinkedIn
Sent to [email protected]

Innovations for Poverty Action
655 15th St. NW, Suite 800
Washington, DC xxxxxx
[email protected]

Manage Your Email Preferences | Forward This Email